McGill.CA / Biomedical Technology & Cell Therapy Research Laboratory / Publications

Research Articles

The BTCTRL has published numerous scientific articles in high-caliber journals. Many of our articles are accessible to the public.

  1. Schaly S, Islam P, Boyajian JL, Thareja R, Abosalha A, Arora K, et al. (2023) Controlled and customizable baculovirus NOS3 gene delivery using PVA-based hydrogel systems. PLoS ONE. 18(9): e0290902.
  2. Schaly S, Islam P, Abosalha A, Boyajian J, Shum-Tim D, Prakash S. (2022). Alginate-chitosan microparticles sustain baculovirus VEGFA gene delivery to promote wound healing and revascularization. Pharmaceuticals. 15(11):1382.
  3. Ahmad W, Boyajian J, Abosalha A, Nasir A, Ashfaq I, Islam P, Schaly S, Thareja R, Hayat A, Anwar M, Prakash S. (2022). High Molecular Weight Dextran-Type Exopolysaccharide Produced by The Novel Apilactobacillus waqarii Improves Metabolic Syndrome: In Vitro and In Vivo Analyses. Int J Mol Sci. 23(20), 12692.

  4. Ahmad W, et al., Prakash S, Anwar M A, Munawaw N. (2022). Whole Genome Sequence Analysis of a Novel Apilactobacillus Species from Giant Honeybee (Apis dorsata) Gut Reveals Occurrence of Genetic Elements Coding Prebiotic and Probiotic Traits. Microorganisms. 10(5):904.

  5. Abosalha A, et al., Prakash S. (2022). A comprehensive update of siRNA design strategies for effective targeting and gene silencing. Expert Opin Drug Discov. 18(2):149-161.

  6. Abosalha A, et al., Prakash S. (2022). Clinical pharmacology of siRNA therapies: current status and future prospects. Expert Rev Clin Pharmacol. 15(11):1327-1341.

  7. Boyajian J, Ghebretatios M, Schaly S, Islam P, Prakash S. (2021). Microbiome and human aging: Probiotic and prebiotic potentials in longevity, skin health and cellular senescence. Nutrients. 13(12), 4550.

  8. Ghebretatios M, Schaly S, Prakash S. (2021). Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases. Int J Mol Sci. 16;22(4):1942. 

  9. Schaly S, Ghebretatios M, Prakash S. (2021). Baculoviruses in Gene Therapy and Personalized Medicine. Biologics. 15:115-132. 

  10. Nikita L, et al., Prakash S. (2021). Synthesis and characterization of peptide conjugated human serum albumin nanoparticles for targeted cardiac uptake and drug delivery. PLoS One. 16(9).

  11. Nikita L, et al., Prakash S. (2021). Albumin Nanoparticle Formulation for Heart-Targeted Drug Delivery: In Vivo Assessment of Congestive Heart Failure. Pharmaceuticals. 14(7):697.

  12. Reyes Valenzuela A, et al., Prakash S, Mongeau L. (2021) Polymeric Microspheres Containing Human Vocal Fold Fibroblasts for Vocal Fold Regeneration. Laryngoscope. 131(8):1828-1834.

  13. Arora K, Green M, and Prakash* S. (2020). The Microbiome and Alzheimer's Disease: Potential and Limitations of Prebiotic, Synbiotic and Probiotic Formulations. Frontiers in Bioengineering and Biotechnology. 14;8:537847.

  14. Green M, Arora K, Prakash* S. (2020). Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome. International Journal of Molecular Sciences. 21(8):2890. 

  15. Dündar M, Mechler A, Alcaraz J, Henehan G, Prakash S, Lal R, Martin DK. (2020). Reflections on Emerging Technologies in Nanomedicine. European Journal of Biotechnology Biosciences. DOI: 10.14744/etd.2020.68542.

  16. Coussa R G, et al., Prakash S, James Oestreicher, Bryan Arthurs (2020). Blink detection and magnetic force generation for correction of lagophthalmos, with specific regard to implant compatibility testing. Orbit. 1-10.

  17. Tomar V, Kumar N, Tomar R, Sood D, Dhiman N, Dass SK, Prakash S, Madan J, Chandra R (2019). Biological Evaluation of Noscapine analogues as Potent and Microtubule-Targeted Anticancer Agents. Scientific Report. Dec 20;9(1):19542.

  18. Westfall S, Lomis, Nikita and Prakash* S. (2019). Ferulic Acid Produced by Lactobacillus fermentum Influences Developmental Growth Through a dTOR-Mediated Mechanism. Molecular Biotechnol. 61(1):1-11. 

  19. Westfall S, Lomis, Nikita and Prakash* S. (2019). A novel synbiotic delays Alzheimer's disease onset via combinatorial gut-brain-axis signaling in Drosophila melanogaster. PLoS One. 14(4):e0214985.

  20. Lim T, et al., Prakash S. (2019). Artificial cell microcapsules containing live bacterial cells and activated charcoal for managing renal failure creatinine: preparation and in-vitro analysis. The EuroBiotech Journal. 3(4) 190-196.

  21. Westfall S, Lomis, Nikita and Prakash* S. (2018). Longevity extension in Drosophila melanogaster through gut-brain-axis communication: examining a novel probiotic and synbiotic formulation. Scientific Report. 30;8(1):8362. Featured in 250+ media/news.

  22. Iqbal UH, Westfall S, Prakash* S. (2018). Novel microencapsulated probiotic blend for use in metabolic syndrome: design and in-vivo analysis. Artif Cells Nanomed Biotechnol. 46: S116-S124.

  23. Duque R, Shan Y, Joya M, Ravichandran N, Asi B, Mobed-Miremadi M, Mulrooney S, McNeil M, Prakash* S. (2018). Effect of artificial cell miniaturization on urea degradation by immobilized E. coli DH5α (pKAU17). Artif Cells Nanomed Biotechnol. 46: 766-775.

  24. Westfall S, Lomis N, Prakash* S. (2018). A novel polyphenolic prebiotic and probiotic formulation have synergistic effects on the gut microbiota influencing Drosophila melanogaster physiology. Artif Cells Nanomed Biotechnol. 46(sup2):441-455.

  25. Khairallah J, Sadeghi Ekbatan S, Sabally K, Iskandar MM, Hussain R, Nassar A, Sleno L, Rodes L, Prakash S, Donnelly DJ, Kubow S. (2018). Microbial Biotransformation of a Polyphenol-Rich Potato Extract Affects Antioxidant Capacity in a Simulated Gastrointestinal Model. Antioxidants (Basel). 7(3).

  26. Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash* S. (2017). Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cellular and Molecular Life Sciences. 74(20):3769-3787.

  27. Lomis N, Gaudreault F, Malhotra M, Westfall S, Shum-Tim D, Prakash S. (2017). A novel milrinone nanoformulation for use in cardiovascular diseases: preparation and in vitro characterization. Molecular Pharmaceutics. 15(7), 2489–2502.

  28. Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali MA, Prakash S. (2017). Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model. Applied Microbiology and Biotechnology. 101(5):1999-2019.

  29. Sadeghi Ekbatan S, Iskandar MM, Sleno L, Sabally K, Khairallah J, Prakash S, Kubow S. (2017). Absorption Metabolism of Phenolics from Digests of Polyphenol-Rich Potato Extracts Using the Caco-2/HepG2 Co-Culture System. Foods (Basel, Switzerland). 7(1):8.

  30. Nhan C, Bezdjian A, Saha S, Prakash S, Nguyen LHP, Daniel SJ.nJ. (2017). 2017 Safety of trans tympanic application of probiotics in a chinchilla animal model. Otolaryngol Head Neck Surg. 46(1):63.

  31. Prasad C, Iqbal U, Westfall S, Prakash S. (2017). Management of hyperuricemia and gout by prebiotics and probiotics: potentials and limitations. Int J Probiotics and Prebiotics. 12(1): 5-16.

  32. Kubow S, Iskandar MM, Melgar-Bermudez E, Sleno L, Sabally K, Azadi B, How E, Prakash S, Burgos G, Felde TZ. (2017). Effects of simulated human gastrointestinal digestion of two purple-fleshed potato cultivars on anthocyanin composition and cytotoxicity in colonic cancer and non-tumorigenic cells. Nutrients. 9(9):953.

  33. Kanevsky J, Vorstenbosch J, Diaz-Abele J, Prinz M, Safran T, Tahiri Y, Gilardino M, Prakash* S (2016). Development and assessment of a cutaneous tissue stretch device as a novel scar therapy. Plastic and Aesthetic Research. 3:351-8.

  34. Pacelli S, Manoharan V, Desalvo A, Lomis N, Jodha KS, Prakash S, Paul A. (2016). Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy. J Mater Chem B Mater Biol Med. 4, 1586-1599.

  35. Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali, Prakash* S. (2016). Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model. Appl Microbiol Biotechnology.  101(5):1999-2019.

  36. Kahouli I, Malhotra M., M. A. Alaoui-Jamali M. A. and Prakash S. et al. (2016). Characterization of L. reuteri NCIMB 701359 potential features for use in colorectal cancer by identifying fatty acid production and anti-proliferative activity against colorectal cancer cells. Drug Design. 2016, 5:2.

  37. Westfall, S., Lomis, N., Singh, S.P., Prakash*, S. (2016). Ferulic acid produced by Lactobacillus fermentum NCIMB 5221 reduces symptoms of metabolic syndrome in Drosophila melanogaster. J. Microbial Biochem. Technology. 8: 272-284.

  38. Nikita Lomis, Susan Westfall, Leila Farahdel, Meenakshi Malhotra, Dominique Shum-Tim, Satya Prakash*. (2016). Human serum albumin nanoparticles for use in cancer delivery: process optimization and in vitro characterization. Nanomaterials (Basel). 6(6): 116.

  39. Urbanska AM, Karagiannis ED, Au AS, Dai SY, Mozafari M, Prakash* S. (2016). What's Next for Gastrointestinal Disorders: No Needles? Journal of Control Release. 221:48-61.

  40. Urbanska AM, Bhathena J, Cherif S, Prakash* S. (2016). Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis. Artif. Cells Nanomed Biotechnol. 44(1):1-11.

  41. Kubow S, Iskandar MM, Sabally K, Azadi B, Sadeghi Ekbatan S, Kumarathasan P, Das DD, Prakash S, Burgos G, Zum Felde T. (2016). Biotransformation of anthocyanins from two purple-fleshed sweet potato accessions in a dynamic gastrointestinal system. Food Chem. 192:171-177.

  42. Imani,R., Shao,W., Taherkhani,S., Emami,S.H., Prakash*,S., & Faghihi,S. (2016). Dual-functionalized graphene oxide for enhanced siRNA delivery to breast cancer cells. Colloids Surf. B Biointerfaces. 147, 315-325.

  43. Block K et al Satya Prakash et al. (2015). Designing a broad spectrum integrative approach to cancer biology, Seminars in Cancer Biology. 11-25.

  44. Martoni, CJ, Labbe, A, Ganopolsky, JG, Prakash S, Jones, ML. (2015). Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolyase active L. reuteri NCIMB 32042. Gut microbes. 6(1):57-65.

  45. Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Rodes L, Prakash* S. (2015). Lactobacillus fermentum NCIMB 5221 and NCIMB 2797 as cholesterol-lowering probiotic biotherapeutics: in vitro analysis. Benef Microbes. 1-10.

  46. Kubow S, Iskandar MM, Sabally K, Azadi B, Sadeghi Ekbatan S, Kumarathasan P, Das DD, Prakash S, Burgos G, Zum Felde T. (2015). Biotransformation of anthocyanins from two purple-fleshed sweet potato accessions in a dynamic gastrointestinal system. Food Chem. 192:171-177.

  47. Wei Shao, Arghya Paul, Laetitia Rodes, Satya Prakash*. (2015). A New Carbon Nanotube-Based Breast Cancer Drug Delivery System: Preparation and In Vitro Analysis Using Paclitaxel. Cell Biochemistry and Biophysics. 71(3):1405-1414.

  48. Singh S et al Prakash and Simgh TD. (2015). Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line. Pharm Biol. 1-6.

  49. Tomaro-Duchesneau C, Jones ML, Shah D, Jain P, Saha S, Prakash* S. (2014) Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation. Biomed Res Int. 2014:380316. 

  50. Amoako-Tuffour Y, Jones ML, Shalabi N, Labbe A, Vengallatore S, Prakash S. (2014). Ingestible gastrointestinal sampling devices: state-of- the-art and future directions. Crit Rev Biomed Eng. 42(1):1-15.

  51. Al Kindi H, Paul A, You Z, Nepotchatykh O, Schwertani A, Prakash* S, Shum-Tim D. (2014). Sustained release of milrinone delivered via microparticles in a rodent model of myocardial infarction. J Thorac Cardiovasc Surg. 148(5):2316-23.

  52. Urbanska AM, Bhathena J, Cherif S, Prakash* S. (2014). Orally delivered microencapsulated probiotic formulation favorably impacts polyp formation in APC (Min/+) model of intestinal carcinogenesis. Artif Cells Nanomed Biotechnol. 2014 Jul 25:1-11.

  53. Jones ML, Ganopolsky JG, Martoni CJ, Labbé A, Prakash* S. (2014). Emerging science of the human microbiome. Gut Microbes. 2014 Jul 11;5(4).

  54. Saha S, Tomaro-Duchesneau C, Rodes L, Malhotra M, Tabrizian M, Prakash* S. (2014). Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics.Beneficial Microbes. 2014 Dec 1;5(4):447-60. 

  55. Rodes L, Saha S, Tomaro-Duchesneau C, Prakash* S. (2014). Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 favorably modulates gut microbiota and reduces circulating endotoxins in F344 rats. Biomed Res Int. 2014;2014:602832.

  56. Jones ML, Tomaro-Duchesneau C, Prakash S. (2014). The gut microbiome, probiotics, bile acids axis, and human health. Trends Microbiol. 2014 Jun;22(6):306-8. 

  57. Fakhoury M, Coussa-Charley M, Al-Salami H, Kahouli I, Prakash* S. (2014). Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice. Curr Drug Deliv. 2014;11(1):146-53

  58. Paul A, Hasan A, Rodes L, Sangaralingam M, Prakash* S. (2014). Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: principles, prospects and challenges. Adv Drug Deliv Rev. 2014 May;71:115-30.

  59. Jones ML, Martoni CJ, Ganopolsky JG, Labbé A, Prakash* S. (2014). The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin Biol Ther. 2014 Apr;14(4):467-82.

  60. Gundala SR, Mukkavilli R, Yang C, Yadav P, Tandon V, Vangala S, Prakash* S, Aneja R. (2014). Enterohepatic recirculation of bioactive ginger phytochemicals is associated with enhanced tumor growth-inhibitory activity of ginger extract. Carcinogenesis. 2014 Jun;35(6):1320-9. 

  61. Rodes L, Saha S, Tomaro-Duchesneau C, and Prakash* S. (2014). Microencapsulated Bifidobacterium longum subsp. infantis ATCC 15697 Favorably Modulates Gut Microbiota and Reduces Circulating Endotoxins in F344 Rats. Biomed Res Int. 2014;2014:602832. 

  62. Jones ML, Tomaro-Duchesneau C, and Prakash* S. (2014). The gut microbiome, probiotics, bile acids axis, and human health. Trends Microbiol. 2014 Jun;22(6):306-8. 

  63. Fakhoury M, Coussa-Charley M, Al-Salami H, Kahouli I, and Prakash* S. (2014). Use of artificial cell microcapsule containing thalidomide for treating TNBS-induced Crohn's disease in mice. Curr Drug Deliv. 2014 Feb;11(1):146-53.

  64. Al Kindi H, Paul A, You Z, Nepotchatykh O, Schwertani A, Prakash S, Shum-Tim* D. (2014). Sustained Release of Milrinone Delivered via Microparticles in a Rodent Model of Myocardial Infarction. The Journal of Thoracic and Cardiovascular Surgery. 148(5):2316-23.

  65. Jones ML, Martoni CJ, Ganopolsky JG, Labbe A, and Prakash* S. (2014). The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opinion Biological Therapy. 14(4):467-82. 

  66. Paul A, Hasan A, Rodes L, Sangaralingam M, and Prakash* S. (2014). Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: Principles, prospects and challenges. Advance Drug Delivery Review. 71:115-30.

  67. Prakash S, Tomaro-Duchesneau C, Saha S, Rodes L, Kahouli I, Malhotra M. (2014). Probiotics for the prevention and treatment of allergies, with an emphasis on mode of delivery and mechanism of action. Current Pharmaceutical Design. 20(6):1025-37.

  68. Marinescu D, Tomaro-Duchesneau C, Malhotra M, Kahouli I, Jones M. L, Rodes L, Prakash* S. (2014). Effect of orally administered APA microencapsulated BSH-active Lactobacillus reuteri NCIMB 30242 on markers of obesity: an in-vivo analysis. Journal of Medical Microbiology. J Microbiol Biotechnol. 23(4):518-26.

  69. Tomaro-Duchesneau C, Saha S, Malhotra M, Rodes L, and Prakash*S. (2014). Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Applied Microbiology and Biotechnology. Vol. 98, 1:115-126.

  70. Paul A, Srivastava S, Chen G, Shum-Tim D, Prakash*, S. (2013). Functional Assessment of Adipose Stem Cells for Xenotransplantation Using Myocardial Infarction Immunocompetent Models: Comparison with Bone Marrow Stem Cells. Cell Biochemistry and Biophysics. 67(2):263-73. 

  71. Malhotra M, Tomaro-Duchesneau C, Saha S, and Prakash* S. (2013). Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer. International Journal Biomaterials. 2013;252531. 

  72. Malhotra M, Tomaro-Duchesneau C, Saha S and Prakash* S. (2013). Intranasal siRNA delivery to the brain by TAT/MGF tagged PEGylated chitosan nanoparticles. Journal of Pharmaceutics. Vol. 2013, Article ID: 812387, 10 pages.

  73. Rodes L, Tomaro-Duchesneau C, Saha S, Paul A, Malhotra M, Marinescu D, Shao W, Kahouli I, and Prakash* S. (2013). Enrichment of Bifidobacterium longum subsp. infantis ATCC 15697 within the human gut microbiota using alginate-poly- l-lysine- alginate microencapsulation oral delivery system: an in vitro analysis using a computer-controlled dynamic human gastrointestinal model. Journal of Microencapsulation. 31(3):230-8.

  74. Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Labbé A, Rodes L, Kahouli I, and Prakash* S. (2013). Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. 98(1):115-26.

  75. Jones, M.L., Martoni,C.J., Ganoplsky, J.,G., Sulemankhil, I, Ghali, P; and Prakash*, S. (2013). Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial. Expert Opinion On Biological Therapy. 13(12):1643-51.

  76. Shao W, Paul A, Zhao B, Lee C, Rodes L, Prakash* S. (2013). Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model. Biomaterials. 34(38):10109-19.

  77. Sinno H, Prakash* S. (2013). Complements and the wound healing cascade: an updated review. Plastic Surgery Int. 2013:146764.

  78. Paul,A., Elias,C.B., Shum-Tim,D., & Prakash*,S. (2013). Bioactive baculovirus nanohybrids for stent based rapid vascular re-endothelialisation. Nature Sci. Rep. 3, 2366 (2013). 

  79. Le Huu A, Paul A, Xu L, Prakash S, Shum-Tim D. (2013). Recent advancements in tissue engineering for stem cell-based cardiac therapies. Therapeutic Delivery. 4(4):503-16. 

  80. Paul A, Shum-Tim D, Prakash* S. (2013). Angiogenic nanodelivery systems for myocardial therapy. Methods Molecular Biology. 1036:137-49. 

  81. Huu AL, Paul A, Prakash S, Shum-Tim D. (2013). Route of delivery, cell retention, and efficiency of polymeric microcapsules in cellular cardiomyoplasty. Methods Molecular Biology. 1036:121-35. 

  82. Sinno H, Malhotra M, Lutfy J, Jardin B, Winocour S, Brimo F, Beckman L, Watters K, Philip A, Williams B, Prakash* S. (2013). Complements c3 and c5 individually and in combination increase early wound strength in a rat model of experimental wound healing. Plastic Surgery International. 2013:243853.

  83. Rodes L, Coussa-Charley M, Marinescu D, Paul A, Fakhoury M, Abbasi S, Prakash*, S. (2013). Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. Journal of Microbiol Biotechnol. 23(4):518-526. 

  84. Malhotra, M, Tomaro-Duchesneau C, Saha S, Kahouli I, Prakash*,S. (2013). Development and characterization of chitosan-PEG- TAT nanoparticles for the intracellular delivery of siRNA. International Journal of Nanomedicine. 8:2041-52.

  85. Saha S, Tomaro-Duchesneau C, Tabrizian M, Prakash* S. (2013). Novel probiotic dissolvable carboxymethyl cellulose films as oral health biotherapeutics: in vitro preparation and characterization. Expert Opinion Drug Delivery.10(11):1471-82.

  86. Prakash* S, Tomaro-Duchesneau C, Saha S, Rodes L, Kahouli I, Malhotra M. (2013). Probiotics For The Prevention And Treatment Of Allergies, With An Emphasis On Mode Of Delivery And Mechanism Of Action. Current Pharmaceutic Design. 20(6):1025-37.

  87. Jones ML, Martoni CJ, and Prakash* S. (2013). Oral Supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-Hydroxyvitamin D: A post hoc analysis of a randomized controlled trial. Journal of Clinical Endocrinology Metabolism. 98(7):2944-51. 

  88. Rodes L, Coussa-Charley M, Marinescu D, Paul A, Fakhoury M, Abbasi S, and Prakash* S. (2013). Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model. Journal of Microbiol Biotechnol. 23(4):518-526. 

  89. Kahouli I, Tomaro-Duchesneau C, and Prakash* S. (2013). Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. Journal of Medical Microbiology. 62(Pt 8):1107-23. 

  90. Rodes L, Coussa-Charley M, Marinescu D, Paul A, Fakhoury M, Abbasi S, and Prakash*, S. (2013). Design of a novel gut bacterial adhesion model for probiotic applications. Artificial Cells, Nanomedicine, and Biotechnology. 41(2):116-24. 

  91. Bhathena J, Martoni C, Kulamarva A, Tomaro-Duchesneau C, Malhotra M, Paul A, Urbanska AM, Prakash* S. (2013). Oral Probiotic Microcapsule Formulation Ameliorates Non-Alcoholic Fatty Liver Disease in Bio F1B Golden Syrian Hamsters. PLoS ONE 8(3). 

  92. Malhotra M, Tomaro-Duchesneau C, and Prakash* S. (2013). Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials. 34, 1270-1280.

  93. Tomaro-Duchesneau C, Saha S, Malhotra M, Kahouli I and Prakash* S. (2013). Microencapsulation for the therapeutic delivery of drugs, live mammalian and bacterial cells and other biopharmaceutics: current status and future directions. Journal of Pharmaceutics. 2013:103527.

  94. Marinescu D, Tomaro-Duchesneau C, Malhotra M, Kahouli I, Jones M. L, Rodes L, Prakash* S. (2013). Effect of orally administered APA microencapsulated BSH-active Lactobacillus reuteri NCIMB 30242 on markers of obesity: an in-vivo analysis. Journal of Medical Microbiology. 23(4):518-26.

  95. Saha S, Tomaro-Duchesneau C, Malhotra M, Tabrizian M and Prakash* S. (2012). Suppression of Streptococcus mutans and Candida albicans by probiotics: an in vitro study. Dentistry. Vol. 2, 6:1-8.

  96. Tomaro-Duchesneau C, Saha S, Malhotra M, Coussa-Charley M, Al-Salami H, Kahouli I, Jones ML, Labbé A, Prakash* S. (2012). Probiotic Ferulic Acid Esterase Active Lactobacillus fermentum NCIMB 5221 Cells APA Microcapsules for Oral Delivery: Preparation and In Vitro Characterization. Pharmaceuticals. 5(2): 236-248.

  97. Saha S, Tomaro-Duchesneau C, Tabrizian M, Prakash* S. (2012). Probiotics as oral health biotherapeutics.Expert Opin Biol Ther. 2012; 12(9):1207-20.

  98. Tomaro-Duchesneau C, Saha S, Malhotra M, Coussa-Charley M, Al-Salami H, Jones ML, Labbé A, Prakash* S. (2012). Lactobacillus fermentum NCIMB 5221 has a greater potential for the production of ferulic acid when compared to other ferulic acid esterase active Lactobacilli. International Journal of Probiotics and Prebiotics. 2012; 7(1):23-32.

  99. Bhathena J*, Tomaro-Duchesneau C*, Martoni C, Malhotra M, Kulamarva A, Urbanska AM, Paul A and Prakash* S. (2012). Effects of orally administered microencapsulated FA-producing L. fermentum on markers of metabolic syndrome: an in vivo analysis. Journal of Diabetes and Metabolism. S2-009.

  100. Sinno H, Malhotra M, Lutfy J, Jardin BA, Winocour S, Brimo F, Beckman L, Watters K, Philips A, Williams B and Prakash* S. (2012). The effects of topical collagen treatment on wound strength and scar cosmesis in rats. The Canadian Journal of Plastic Surgery. 20, 3:181-185.

  101. Sinno H, Malhotra M, Lutfy J, Jardin BA, Winocour S, Brimo F, Beckman L, Watters K, Philips A, Williams B and Prakash* S. (2012). Accelerated Wound Healing with Topical Application of Complement C5. Plastic and Reconstructive Surgery journal. 130, 3:523-529.

  102. Shao W, Paul A, Abbasi S, Chahal PS, Mena JA, Montes J, Kamen A, Prakash* S. (2012). A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis. Int. J of Nanomedicine. 1575 – 1586.

  103. Paul A , Shao W , Shum-Tim D , Prakash* S. (2012). The attenuation of restenosis following arterial gene transfer using carbon nanotube coated stent incorporating TAT/DNA(Ang1+Vegf) nanoparticles. Biomaterials. 33(30):7655-64.

  104. Afkhami F, Durocher Y, Prakash* S. (2012). Microencapsulated mammalian cells for simultaneous production of VEGF165b and IFNα. Artif Cells Blood Substit Immobil Biotechnol. 40(1-2):1-6.

  105. Sulemankhil I , Parent M , Jones ML , Feng Z , Labbé A , Prakash* S. (2012). In vitro and in vivo characterization and strain safety of Lactobacillus reuteri NCIMB 30253 for probiotic applications Canadian journal of microbiology. 58(6): 776-87.

  106. Jones ML, Martoni CJ, Tamber S, Parent M, Prakash* S. (2012). Evaluation of safety and tolerance of microencapsulated Lactobacillus reuteri NCIMB 30242 in a yogurt formulation: a randomized, placebo-controlled, double-blind study. Food Chem. Toxicol. 50(6):2216-23.

  107. Coussa RG, Shah S, Jain P, Martoni C, Bhathena J, Malhotra M, Prakash* S. (2012). Microencapsulated Saccharomyces cerevisiae column bioreactor for potential use in renal failure uremia. Artif Cells Blood Substit Immobil Biotechnol. 40(1-2):103-12.

  108. Le Huu A, Prakash S, Shum-Tim D. (2012). Cellular cardiomyoplasty: current state of the field. Regenerative medicine. 7(4): 571-82.

  109. Abbasi S, Paul A, Shao W , Prakash* S. (2012). Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment. Journal of drug delivery. 2012:686108.

  110. Jones ML, Martoni CJ, Di Pietro E , Simon RR , Prakash* S. (2012). Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: A randomized control trial. Regulatory toxicology and pharmacology: RTP. 63(2): 313-20.

  111. Jardin BA, Elias CB, Prakash* S. (2012). Expression of a secreted protein in mammalian cells using baculovirus particles. Methods in molecular biology. 801: 41-63.

  112. Jones M , Ganopolsky JG , Labbé A , Gilardino M , Wahl C , Martoni C , Prakash* S. (2012). Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds. International wound journal. 9(3): 330-4

  113. Jones ML, Martoni CJ, Parent M, Prakash* S. (2012). Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. British Journal of Nutrition. 107(10):1505-13.

  114. Paul A, Chen G, Khan A A, Rao V, Shum-Tim D, Prakash* S. (2012). Genipin-crosslinked microencapsulated human adipose stem cells augment transplant retention resulting in attenuation of chronically infarcted rat heart fibrosis and cardiac dysfunction. Cell Transplantation. 21(12):2735-51.

  115. Paul A, Nayan M, Khan AA, Shum-Tim D, Prakash* S. (2012). Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction. Int J Nanomedicine. 7:663-82.

  116. Prakash*S, Malhotra M, Shao W, Tomaro-Duchesneau C, Abassi S. (2011). Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Advanced Drug Delivery Reviews. 63(14-15):1340-51.

  117. Paul A, Srivastava S, Chen G, Shum-Tim D, Prakash* S. (2011). Functional Assessment of Adipose Stem Cells for Xenotransplantation Using Myocardial Infarction Immunocompetent Models: Comparison with Bone Marrow Stem Cells. Cell Biochem Biophys. 67(2):263-73.

  118. Rodes L, Paul A, Coussa-Charley M, Al-Salami H, Tomaro-Duchesneau C, Fakhoury M, Prakash* S. (2011). Transit time affects the community stability of lactobacillus and bifidobacterium species in an in vitro model of human colonic microbiotia. Artif Cells Blood Substit Immobil Biotechnol. 39(6):351-6

  119. Paul A, Binsalamah ZM, Khan AA, Abbasia S, Elias CB, Shum-Tim D, and Prakash* S. (2011). A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials. 32(32):8304-18. 

  120. Prakash* S, Rodes L, Coussa-Charley M, and Tomaro-Duchesneau C. (2011). Gut microbiota: next frontier in understanding human health and development of biotherapeutics. Biologics. 5:71-86. 

  121. Nayan M, Paul A, Chen G, Chiu RC, Prakash S, and Shum-Tim D. (2011). Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardial delivery in aged recipients with acute myocardial infarction: in vitro and in vivo investigation. J Tissue Eng. 2011:741213. 

  122. Prakash* S, Tomaro-Duchesneau C, Saha S, Cantor A. (2011). The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells. J Biomed Biotechnol. 2011:981214.

  123. Bhathena J, Kulamarva A, Martoni C, Malgorzata A, Malhotra UM, Paul A, Prakash* S. (2011). Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. Diabetes Metab Syndr Obes. 4:195-203. 

  124. Burdon T, Paul A, Noiseux N, Prakash S, and Dominique* S. (2011). Bone Marrow Stem Cell Derived Paracrine Factors for Regenerative Medicine: Current Perspectives and Therapeutic Potential. Bone Marrow Research. 2011:207326.

  125. Malhotra M, Lane C, Tomaro-Duchesneau C, Saha S and Prakash* S. (2011). A novel scheme for synthesis of PEG-grafted-chitosan polymer for preparation of nanoparticles and other applications. International Journal of Nanomedicine. Vol. 2011, 6: 485-494.

  126. Malhotra M, Nambiar S, Rengaswamy V and Prakash* S. (2011). siRNA design strategies for effective targeting and gene silencing. Expert Opinion on Drug Discovery. Vol. 6, 3: 269-289.

  127. Malhotra M and Prakash* S. (2011). Cell penetrating peptides based nanoparticles for targeted delivery of therapeutic molecules across blood brain barrier: potential and limitations. Current Nanosciences. 2011; Vol. 7, 1: 81-93.

  128. Al-Kindi AH, Asenjo JF, Ge Y, Chen GY, Bhathena J, Chiu RC, Prakash S, Shum-Tim D*. (2011). Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy. European Journal of Cardiothoracic Surgery. Vol. 39: 241-247.

  129. Apte SS, Paul A, Prakash S, Shum-Tim D*. (2011). Current developments in the tissue engineering of autologous heart valves: moving towards clinical use. Future Cardiology. Vol. 7(1) 77-97.

  130. Branton, W. B., Jones, M. L., Tomaro-Duchesneau, C., Martoni, C. J., Prakash* S. (2011). In-vitro characterization and safety of the probiotic strain Lactobacillus reuteri cardioviva NCIMB 30242. International journal of probiotics and prebiotics. 6(1):1-12.

  131. Khan A, A Paul*, Abbasi S*, Prakash* S. (2011). Mitotic and antiapoptotic effects of nanoparticles co-encapsulating hVEGF and hAng-1 can induce on vascular endothelial cells. International Journal of Nanomedicine. 6: 1069–1081.

  132. Paul A, Shum-Tim D, Prakash* S. (2010). Investigation on PEG Integrated Alginate–Chitosan Microcapsules for Myocardial Therapy Using Marrow Stem Cells Genetically Modified by Recombinant Baculovirus. Cardiovascular Engineering and Technology. ol 1(2): 154-164.

  133. Paul A, Khan A, Shum-Tim D, Prakash* S. (2010). BacMam virus transduced cardiomyoblasts can be used for myocardial transplantation using AP-PEG-A microcapsules: molecular cloning, preparation and in vitro analysis. Journal of Biomedicine and Biotechnology Vol. 1-12,2010.

  134. Paul A, Jardin BA, Kulamarva A, Malhotra M, Elias CB, Prakash* S. (2010). Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: molecular cloning, expression, and in vitro characterization.Mol Biotechnol. 2010; Vol. 45(2):129-39

  135. Paul A, ElHayek E, Shum-Tim D, Prakash* S. (2010). Recent Advancements in Pharmacological Stent Therapy using Polymeric Materials: Opportunities and Challenges. Current Drug Delivery journal. 2010; Vol 7(3):216-224

  136. Paul A, Abbasi S, Shum-Tim D, Prakash* S. (2010). Nano-bioengineering approaches in current and future generation of cardiovascular stents. Current Nanoscience. 2010; Vol. 6(5):469-478.

  137. Urbanska A, Paul A, Bhathena J, Prakash* S. (2010). Suppression of Tumorigenesis: Modulation of Inflammatory Cytokines by Oral Administration of Microencapsulated Probiotic Yogurt Formulation. International Journal of Inflammation. 2010; Vol 2010, Article ID 894972, doi:10.4061/2010/894972.

  138. Paul A and Prakash* S. (2010). Baculovirus reveals a new pH-dependent direct cell-fusion pathway for cell entry and transgene delivery. Future Virology. 2010; Vol. 5(5): 533-537.

  139. Prakash* S, Khan A and Paul A. (2010). Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential. Expert Opin Biol Ther. 2010; Vol. 10(12):1649-61.

  140. Paul A, Cantor A, Shum-Tim D, Prakash* S. (2010). Superior stem cell delivery features of genipin crosslinked polymeric microcapsules: preparation and in vitro characterization using human adipose stem cells. Molecular Biotechnology. 2010

  141. Chen H, Ouyang W, Martoni C, Afkhami F, Lawuyi B, Lim T and Prakash* S. (2010). Investigation of genipin cross-linked microcapsule for oral delivery of live bacterial cell and other biotherapeutics: preparation and in-vitro analysis in simulated human gastrointestinal model. International Journal of Polymer Science. 2010; Vol 2010

  142. Afkhami F, Durocher Y and Prakash* S. (2010). Investigation of anti-angiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells. Journal of Biomedicine and Biotechnology. 2010

  143. Sebak S, Mirzaei M, Malhotra M, Kulamarva A, and Prakash* S. (2010). Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int. J. Nanomedicine. 2010; Vol. 2010(5): 525-532. 

  144. Coussa R, Martoni C, Bhathena C, Urbanska AM and Prakash* S. (2010). Oral Microencapsulated Live Saccharomyces Cerevisiae Cells for Use in Renal Failure Uremia: Preparation and in-Vivo Analysis, Journal of Biomedicine and Biotechnol. 2010

  145. Jones, M. L., Ganopolsky JG, Labbe A, Wahl C, and Prakash S. (2010). Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. Applied Microbiology and Biotechnology. 2010; Vol. 88(2): 401-407.

  146. Jones M, Ganopolsky JG, Labbe A, and Prakash* S. (2010). Novel nitric oxide producing probiotic wound healing patch and its antimicrobial efficacy: preparation and in vitro analysis. Applied Microbial Biotechnology. 2010; Vol. 87(2):509-16.

  147. Singh P, Kumar P, Katyal A, Kalra R, Dass SK, Prakash S, Chandra R. (2010). Synthesis and electrochemical studies of charge-transfer complexes of thiazolidine-2,4-dione with sigma and pi acceptors. Spectrochim Acta A Mol Biomol Spectrosc. 2010. 75(3):983-91.

  148. Paul A, Ge Y, Prakash* S, Shum-Tim D. (2009). Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy.Regen Med. 2009 Sep;4(5):733-45.

  149. Malhotra M, Kulamarva A, Sebak S, Paul A, Bhathena J, Mirzaei M, Prakash* S. (2009). Ultra-small nanoparticles of low molecular weight Chitosan as an efficient delivery system targeting neuronal cells. Drug Development and Industrial Pharmacy. Vol. 35, 6:719-726.

  150. Bhathena J, Martoni C, Kulamarva A, Urbanska A, Malhotra M and Prakash* S. (2009). Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters. Journal of Medicinal Food. Vol. 12, 2:310-9

  151. Arun Kulamarva , Pavan Raja, Jasmine Bhathena, Hongmei Chen, Saikat Talapatra, Pulickel Ajayan, Omkaram Nalamasu and Satya Prakash. (2009). Microcapsule carbon nanotube devices for therapeutic applications. Nanotechnology. Vol. 20 (2) 025612 (7pp)

  152. Arun Kulamarva , Jasmine Bhathena, Meenakshi Malhotra, Safaa Sebak, Pulicke Ajayan and Satya Prakash*. (2008). In-vitro cytotoxicity of functionalized single walled carbon nanotubes for targeted gene delivery applications. Nanotoxicology (in press).

  153. Maryam Mirzaei, Barabara Jardin, Cynthia Elias and Satya Prakash*. (2008). Non-viral production of human Interleukin-7 in Spodoptera frugiperda insect cells as a soluble recombinant protein. Journal of Biomedicine and Biotechnology. (in press). Funding: NSERC 239094.

  154. Christopher Martoni, Jasmine Bhathena, Mitchell Lawrence Jones, Aleksandra Urbanska, Hongmei Chen, and Satya Prakash*. (2008). Preparation and in-vitro analysis of microencapsulated genetically engineered Lactobacillus Plantarum 80 BSH overproducing cells for oral delivery as a cholesterol lowering therapy. Journal of Biotechnology (in press).

  155. Hongmei Chen, Wei Ouyang, Jasmine Bhathena, Christopher Martoni, and Satya Prakash*. (2008). Investigation of microcapsules for potential oral applications using a dynamic simulated human gastrointestinal model. Letters in Drug Delivery (in press).

  156. Aleksandra Urbanska, Jasmine Bhathena, Arun Kulamarva, Christopher Martoni, and Satya Prakash*. (2008). Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the progression of colon cancer in Apc(Min/+) mice. Digestive Diseases and Sciences, Jul 17.

  157. Maryam Mirzaei , Barbara Jardin,Cynthia B. Elias, and Satya Prakash*. (2008). Expression and production of human Interleukin-7 in insect cells using Baculovirus Expression Vector System (BEVS). Applied Biochemistry and Biotechnology June 11

  158. Christopher Martoni, Jasmine Bhathena, Mitchell Lawrence Jones, Aleksandra Urbanska, Hongmei Chen, and Satya Prakash*. (2008). Microencapsulated bile salt hydrolase producing L. reuteri for oral targeted delivery in the gastrointestinal tract. Applied Microbiology and Biotechnology Aug 22.

  159. Prakash* S, Malhotra M. (2008). Recent advancements in targeted delivery of therapeutic molecules in neurodegenerative disease - spinocerebellar ataxia - opportunities and challenges. Drug Target Insights, 3, pp 99-117

  160. Satya Prakash* and Aleksandra Urbanska. (2008). Feasibility and efficacy in delivery of live probiotic bacterial cells: gastrointestinal diseases with emphasis on colonic targeting, Biologics: Targets & Therapy, 2(3), 355–378.

  161. Barbara Jardin, Zhao Y, Sivraj M., Motes, J., Trans R, Prakash* Satya and Elias CB*. (2008). Expression of SEAP (secreted alkaline phosphatase) by baculovirus mediated transduction of HEK293 cells in a hollow fiber bioreactor system. Journal of Biotechnology. Jun 30; 135( 3): 272-80, Funding: NSERC 239094.

  162. Satya Prakash * and Jasmine Bhathena. (2008). Live immobilized cells as new therapeutics. Journal of Drug Delivery Science and Technology Vol. 1 8(1): 3-14.

  163. Bhathena J., Kulamarva A. Urbanska Aleksandra Malgorzata, Martoni Christopher, and Prakash* S. (2008). Preparation and in-vitro analysis of microencapsulated live Lactobacillus fermentum 11976 for augmentation of feruloyl esterase in the gastrointestinal intestinal tract. Biotechnology and Applied Biochemistry . Jul 20. vol. 75, no. 5, pp. 1023–1029.

  164. Urbanska A. M., Bhathena J., and Prakash *Satya. (2007). Live encapsulated Lactobacillus acidophilus cells in yogurts for therapeutic oral delivery: preparation and in-vitro analysis of alginate-chitosan microcapsules. Canadian Journal of Physiology and Pharmacology. Sep; 85 ( 9): 884-93.

  165. AlKindi, A., Chen, G., Ge, Y., Bhathena, J., Chiu, R., Prakash*, S., Shum-Tim, D. (2007). Microencapsulated stem cell retention for localized cardiac cell delivery. Canadian Journal of Cardiology; Vol. 23:77C.

  166. Bisi Lawuyi, Hongmei Chen, Fatemeh Afkhami, Arun Kulamarva, Satya Prakash*. (2007). Microencapsulation of engineered Lactococcus lactis in alginate-poly-l-lysine-alginate capsules for heterologous protein delivery. Applied Biochemistry and Biotechnology. 142, 1, 71-80.

  167. Martoni C, Bhathena J, Jones ML, Urbanska AM, Chen H, Prakash* S. (2007). Investigation of Microencapsulated BSH Active Lactobacillus in the Simulated Human GI Tract. Journal of Biomedicine and Biotechnology. ( 7): 13684.

  168. Satya Prakash* and Arun Kulamarva. (2007). Recent advances in drug delivery: Potential and Limitations of Carbon Nanotubes. Recent patents in drug delivery and formulations. Bentham Publications, USA. Pp. 214-221.

  169. Bhathena J., Kulamarva A. Urbanska Aleksandra Malgorzata, Christopher Martoni, and Prakash* S. (2007). Microencapsulated bacterial cells can be used to produce the enzyme feruloyl esterase: Preparation and in-vitro analysis. Applied Microbiology and Biotechnology, Jul; 75(5):1023-1029 .

  170. Aleksandra Malgorzata Urbanska, Jasmine Bhathena, and Satya Prakash*. (2007). Live encapsulated Lactobacillus acidophilus cells in yogurts for therapeutic oral delivery: preparation and in-vitro analysis of alginate-chitosan microcapsules. International Journal of Prebiotics and Probiotics. 3, Aug. 225-229.

  171. Al-Kindi, A., Chen, G., Asenjo, J.F., Ge, Y., Bhathena, J., Chiu, R, Prakash, S., Shum-Tim, D. (2007). Circulation; Vol. 116(16):591-592.

  172. Manisha Tiwari and Ramesh Chandra Sujata K. Das and Satya Prakash*. (2007). Tin Mesoporphyrin in Conjunction with Retinoic Acid Reverses the Retinoic Acid Induced Enhancement of Phospholipase A2 Activity in vivo in Rats. Artificial Cells, Blood Substitute and Biotechnology. 35: 1–11.

  173. Hongmei Chen, Mitchell L Jones, Wei Ouyang, Terrence Metz, Christopher Martoni, Tasima Haque, Rebecca Cohen, Bisi Lawuyi, and Satya Prakash*. (2007). Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy. Cell Biochemistry and Biophysics. Vol., 47, Issue No.1, 158-162.

  174. Afkhami F, Ouyang W, Chen H, Lawuyi B, Lim T, Prakash *, S. (2007). Impact of orally administered microcapsules on gastrointestinal microbial flora: in-vitro investigation using computer controlled dynamic human gastrointestinal model. Artificial Cells Blood Substitute Immobilization Biotechnology. 35( 4): 359-75.

  175. Aleksandra Malgorzata Urbanska, Wei Ouyang, Jasmine Bhathena, Christopher Martoni, and Satya Prakash*. (2006). Investigation of the viability of microencapsulated live Lactobacillus acidophilus cells for their use in probiotic yogurts. International Journal of Probiotics and Prebiotics. Vol. 1, No. 2. 121-137.

  176. Hongmei Chen, Wei Ouyang, Bisi Lawuyi, Trisna Lim, and Satya Prakash*. (2006).A new method for microcapsule characterization: fluorogenic genipin can be used to characterize polymeric microcapsule membranes.Applied Biochemistry and Biotechnology. Vol.,134, 207-231.Featured Article for the Issue.

  177. Terrence Metz, Hongmei Chen, Devendra Amre, S.K. Das and Satya Prakash*. (2006).Preparation and in-vitro analysis of microcapsule thalidomide formulation for targeted suppression of TNF-α. Drug delivery. 2006 Sep-Oct;13(5):331-337.

  178. Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi Lawuyi, and Satya Prakash*. (2006). Genipin Cross-linked Alginate-Chitosan Microcapsules: Membrane Characterization and Optimization of Cross-linking Reaction. Biomacromolecules. Jul;7(7):2091-2098.

  179. Satya Prakash*and Christopher John Martoni. (2006). Towards a New Generation of Bacterial Cell Therapy: Artificial Cells as a Vehicle for Safe and Effective Delivery of Probiotics. Applied Biochemistry and Biotechnology. 128(1):1-22.

  180. Hongmei Chen, Wei Ouyang, Bisi Lawuyi, Christopher Martoni and Satya Prakash*. (2005). Reaction of chitosan with genipin and its fluorogenic attributes for potential microcapsule membrane characterization Journal of Biomedical Materials Research Part A. 15;75(4):917-27.

  181. Hongmei Chen, Wei Ouyang, Mitchell Jones, Tasima Haque, Bisi Lawuyi and Satya Prakash*. (2005). In-vitro analysis of APA microcapsules for oral delivery of live bacterial cells.Journal of Microencapsulation 22(5):539-47.

  182. Satya Prakash* and Jasmine Bhathena. (2005). Live bacterial cells as orally delivered therapeutics. Expert Opinion on Biological Therapy. Ashley Publications Ltd. London, UK (2005) 5(10), 1281-1301.

  183. Tasima Haque, Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi Lawuyi, Alexandra Urbanska, and Satya Prakash*. (2005). Investigation of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-l-lysine for cell transplantation applications, International Journal of Artificial Organs; 28(6):631-617 .

  184. Tasima Haque, Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi Lawuyi, Aleksandra Malgorzata Urbanska, and Satya Prakash*. (2005). Superior cell delivery features of poly-ethylene glycol incorporated alginate, chitosan and poly-l-lysine microcapsules, Molecular Pharmaceutics. Vol 2, N0.1 29-36.

  185. Ritu Aneja, Gunjan Upadhyaya, Satya Prakash*, Sujata K. Dass and Ramesh Chandra. (2005). Ameliorating effect of phytoestrogens on ccl4-induced oxidative stress in the livers of male wistar rats. Artificial Cells, Blood Substitute and Biotechnolog y; 33(2):201-213.

  186. Metz, Terrence; Jones, Mitchell L.; Chen, Hongmei; Halim, Trisnawati; Mirzaei, Maryam; Haque, Tasima; Amre, Devendra; Das, Sujata K.; Prakash, Satya*. (2005). A New Method for Targeted Drug Delivery Using Polymeric Microcapsules: Implications for Treatment of Crohn's Disease. Cell Biochemistry and Biophysics, Volume 43, Issue 1, page 77-86.

  187. Tasima Haque, Hongmei Chen, Wei Ouyang, Christopher Martoni, Bisi L awuyi, Aleksandra Malgorzata Urbanska, and Satya Prakash*. (2005). Alginate-chitosan microcapsules: in-vitro analysis for liver cell encapsulation and therapy. Biotechnology Letters Mar; 27(5):317-322.

  188. Ritu Jain, Manisha Tiwari, Gunjhan Upadhyaya, Satya Prakash* and Ramesh Chandra. (2005). The use of Riboflavin and Metalloporphyrins in cytochrome P-450 in Wistar Rats. Artificial Cells, Blood Substitute and Biotechnology. 2005;33(3):271-278 (listed incorrect in pubmed).

  189. Prakash S, * and Jones ML. (2005). Artificial Cell Therapy: New Strategies for the Therapeutic Delivery of Live Bacteria. Journal of Biomedicine Biotechnology: (1):44-56.

  190. Mitch Lawrence Jones, Hongmei Chen, Wei Ouyang, Terrence Metz, and Satya Prakash*. (2005). Deconjugation of Bile Acids with Immobilized Genetically engineered Lactobacillus plantarum 80 (pCBH1). Applied Bionics and Biomechanics, Vol.2, No 1, 1-8.

  191. Wei Ouyang, Hongmei Chen, Terrence Metz, Mitch Lawrence, Jones and Satya Prakash*. (2004). Artificial cell for oral delivery of live bacterial cells for therapy: preparation and in-vitro characterizations. Journal of Pharmacy and Pharmaceutical Science. 7(3)315-324. Featured as Editorial in lead drug delivery updates and was distribute to more than 7000 drug companies and drug discovery and other researchers.

  192. Terrence Metz, Devendra Amre, Mitchell L. Jones, Wei Ouyang, Hongmei Chen, Tasima Haque Christopher Martoni, and Satya Prakash*. (2004). Artificial cell microcapsule containing Thalidomide as an alternative oral therapy method for Crohn’s Disease (CD). Pediatric Gastroenterology, Hepatology and Nutrition, Page 565-571.

  193. Satya Prakash * and Hahn Soe-Lin. (2004). Strategy for cell therapy: polymers for live cell encapsulation and delivery. Trends in Biomaterials & Artificial Organs, 18, 1, 24-35.

  194. Mitch Lawrence Jones, Hongmei Chen, Wei Ouyang, Terrence Metz, and Satya Prakash*. (2004). Microencapsuled Genetically Engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation. Journal of Biomedicine and Biotechnology, 2004(1):61-69.

  195. Ritu Aneja, Sujata K. Dass, Satya Prakash* and Ramesh Chandra. (2004). Effect of gossypol in association with chromium protoporphyrin on heme metabolic enzymes. Artificial Cells, Blood Substitute and Biotechnology, 32, 1, 159-172.

  196. Mitch Lawrence Jones, Hongmei Chen, Wei Ouyang, Terrence Metz, and Satya Prakash*. (2003). Method for measuring bile acid. Journal of Medical Sciences. 23(5), 277-280.

  197. Chow, JN, Liu ,ZC, Prakash, S and Chang*, TMS. (2003). Free and Microencapsulated Lactobacillus and effects of metabolic induction on Urea Removal.  Artificial Cells, Blood Substitutes and Biotechnology, Volume 31, Number 4, 425-435.

  198. Chang TM* and Prakash S. (2001). Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms. Molecular Biotechnology. 17(3):249-260.

  199. Prakash, S. and Chang*, T.M.S. (2000). Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo. Artif. Cells, Blood Substitutes & Immob. Biotechnology, an International journal, Sep 28:5 397-408.

  200. Prakash, S. and Chang*, T.M.S. (2000). In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells. Int. J. Artif. Organs, 23:7 429-435.

  201. Prakash, S. and Chang*, T.M.S. (1999). Growth kinetics of genetically engineered E. coli DH 5 cells in artificial cell APA membrane microcapsules: preliminary report.Artificial Cells Blood Substitute and Immob. Biotech., an International Journal (27(3), 291-301.

  202. Chang*, T.M.S. and Prakash, S. (1999). Handbook of Cell Encapsulation: Tissue Engineering: Cell Encapsulation Technology and Therapeutics. (29) 379-391.

  203. Prakash, S. and Chang*, T.M.S. (1999). Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary report. Artif. Cells Blood Subst. Immobil. Biotechnol. 27:5-6 475-481.

  204. Chang*, T.M.S. and Prakash, S. (1998). Therapeutic uses of microencapsulated genetically engineered cells. Molecular Medicine Today (221-227). Features the cover page of the issue.

  205. Prakash, S. and Chang*, T.M.S. (1998). Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal. Artificial Cells Blood Substitute and Immob. Biotech., an International Journal,26(1) 35-51.

  206. Chang*, T.M.S. and Prakash, S. (1997). Artificial cells for bioencapsulation of cells and genetically engineered E. coli for cell therapy, gene therapy, and removal of urea and ammonia. Methods in Molecular Biology, 63, 343-348.

  207. Prakash, S. and Chang*, T.M.S. (1996). Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.Artificial Cells Blood Substitute and Immobilization Biotechnology, an International Journal,24(3) 201-218.

  208. Prakash, S. and Chang*, T.M.S. (1996). Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats. Nature Medicine,2(8) 893-887. (Impact Factor (IF) for Nature Medicine was 27.12 compared to IF for Nature =28, and IF for Science 28.65 in year 1998 by science citation index).

  209. Prakash, S. and Chang*, T.M.S. (1995). IEEE Transaction in Biomedical Engineering, 7,111-112.

  210. Prakash, S. and Chang*, T.M.S. (1995). Preparation and in-vitro analysis of Engineered E. coli DH5 cells, microencapsulated in artificial cells for urea and ammonia removal. Biotechnology and Bioengineering. 46, 687-697.

  211. Prakash, S. and Chang*, T.M.S. (1993). Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal. Biomaterials Artificial Cells and Immobilization Biotechnology. 21 (5), 629-636.

Back to top